![With Few New Clotting Cases, Johnson & Johnson Pause Could Be Lifted Soon](https://static01.nyt.com/images/2021/04/22/us/politics/22dc-virus-jandj-3/22dc-virus-jandj-3-facebookJumbo.jpg)
With Few New Clotting Cases, Johnson & Johnson Pause Could Be Lifted Soon
The New York Times
Top federal health officials said in interviews this week that the number of rare blood clotting disorders in recipients of the Johnson & Johnson vaccine has remained small.
WASHINGTON — Federal health officials are leaning toward lifting their recommended pause on the use of Johnson & Johnson’s coronavirus vaccine after finding only a limited number of additional cases of a rare blood clotting disorder among recipients. Instead, the Food and Drug Administration is considered likely to attach a warning to the vaccine’s label to inform health practitioners — and the public — about the exceedingly uncommon, but dangerous possible side effect. Federal health officials are waiting to act until they hear from a committee of outside experts who advise the C.D.C. The committee is scheduled to meet on Friday to discuss whether to recommend lifting, extending or modifying the pause that was initiated on April 13.More Related News